Peakman M, Tree T I, Endl J, van Endert P, Atkinson M A, Roep B O
Department of Immunology, Guy's King's and St. Thomas' School of Medicine, London, United Kingdom.
Diabetes. 2001 Aug;50(8):1749-54. doi: 10.2337/diabetes.50.8.1749.
The identification, quantification, and characterization of T-cells reactive with the islet autoantigens GAD65, proinsulin (PI), and tyrosine phosphatase-like molecules IA-2 and phogrin are major research goals in type 1 diabetes. In the Immunology of Diabetes Society First Workshop on Autoreactive T-Cells, the quality of recombinant preparations of these autoantigens was identified as a significant weakness, a finding that may account for much of the inconsistency in published studies of peripheral blood T-cell reactivity to islet autoantigens. Poor antigen quality has also hampered the development of novel technologies for the detection of islet-reactive T-cells. For these reasons, in the present study, several preparations of GAD65, PI, and IA-2 were collected and evaluated for endotoxin content, ability to stimulate a panel of relevant T-cell clones, and inhibitory effects on proliferation to unrelated third-party antigens. Through this process, we have been able to identify preparations of GAD65 and IA-2, generated in insect cells using the baculovirus expression system, that stimulate relevant clones and display low inhibitory effects on third-party antigens. In addition, we characterized a PI preparation generated in bacteria as being free of effects on proliferation to third-party antigens and low in endotoxin content. These preparations are important to promote the development of robust and sensitive assays of islet-reactive T-cells in patients with type 1 diabetes or patients at high risk for developing the disease.
鉴定、定量以及表征与胰岛自身抗原谷氨酸脱羧酶65(GAD65)、胰岛素原(PI)、酪氨酸磷酸酶样分子IA-2和phogrin发生反应的T细胞是1型糖尿病的主要研究目标。在糖尿病免疫学会关于自身反应性T细胞的首次研讨会上,这些自身抗原重组制剂的质量被认定为一个重大缺陷,这一发现或许可以解释已发表的外周血T细胞对胰岛自身抗原反应性研究中存在的诸多不一致之处。抗原质量欠佳也阻碍了用于检测胰岛反应性T细胞的新技术的开发。基于这些原因,在本研究中,我们收集了几种GAD65、PI和IA-2制剂,并对内毒素含量、刺激一组相关T细胞克隆的能力以及对无关第三方抗原增殖的抑制作用进行了评估。通过这一过程,我们得以鉴定出利用杆状病毒表达系统在昆虫细胞中产生的GAD65和IA-2制剂,它们能够刺激相关克隆,并且对第三方抗原的抑制作用较低。此外,我们鉴定出一种在细菌中产生的PI制剂,它对第三方抗原的增殖没有影响,且内毒素含量较低。这些制剂对于推动针对1型糖尿病患者或有患该病高风险的患者开发强大且灵敏的胰岛反应性T细胞检测方法至关重要。